-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
selected
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Respiratory system
-
Resource Type
- NICE Guidance
- Programme
- Year
- prev
- Page 9 of 2
17 results found filtered by Evidence Remove Evidence Filter Scrutiny Remove Scrutiny Filter 2003 Remove 2003 Filter 2008 Remove 2008 Filter 2010 Remove 2010 Filter NICE Guidance Remove NICE Guidance Filter Clear Search
-
Appraisal Guidance No 72 - use of anakinra for rheumatoid arthritis
- Published
- 26 November 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 73 - Myocardial perfusion scintigraphy
- Published
- 26 November 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 69 - the use of liquid based cytology for cervical screening
- Published
- 22 October 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 70 - Use of imatinib for chronic myeloid leukaemia
- Published
- 22 October 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 71 - Use of coronary artery stents
- Published
- 22 October 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 68 - Photodynamic therapy for age-related macular degeneration
- Published
- 24 September 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance 65 - the use of rituximab for aggressive non-hodgkin's lymphoma
- Published
- 24 September 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance 64 - use of somatropin in adults with growth hormone deficiency
- Published
- 17 September 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 66 - the use of newer drugs for bipolar disorder
- Published
- 20 August 2003
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 63 - use of glitazones for the treatment of type 2 diabetes
- Published
- 28 May 2003
- Cycle of Improvement
- Evidence